Cytokast 50mg Injection
Prescription Required
Marketed By
Aprazer Healthcare Pvt Ltd
Pack of
1 Injection
Salt Composition
Cisplatin Injection IP
Storage
Keep in cold place
₹277.84₹347
19.93% Off
Inclusive of all taxes
1
Cytokast 50mg Injection
Delivering To: —
All Substitutes
Overview
null
Indication
Advanced Cancer of the bladder, Advanced Cancer of the Testicles
Description
Cytokast 50mg Injection is a doctor's prescribed anticancer injection that is used to multiple types of cancers including Blood Cancers, Breast Cancer, Ovarian Cancer and Neuroblastoma.Cytokast 50mg Injection contains cyclophosphamide as its active salt. It inhibits cancer cell replication and lead to cancer cell death, primarily in proliferating cells. As a result, cancer cell growth stops.
Common Side Effects
Cytokast 50mg Injection is a chemical salt based anticancer injection. Its salt in reaction with the body leads to numerous side effects like any other chemical medication.Symptoms may vary from mild to severe. If these side effects remain for longer period of time, consult your doctor immediately.
● Hair loss
● Mouth Sores
● Nausea
● Weakness
● Low Red, White and Platelets Blood Cell Count
● Fluid Retention
● Muscle Pain
● Nail Change
● Febrile Nutropenia
● Allergic Reactions
● Peripheral Neuropathy
● Liver Toxicity
● Painful Urination
● Infection Risk
● Pneumonitis
● Secondary Cancer or Diseases
Dosage And Administration
Cytokast 50mg Injection is administered intravenously (In Veins) by a doctor or an experienced nurse. It is advice not to self administer the injection on your own. For personalized dosage ask your doctor about the same. As Dosage is entirely based on the body surface area, type of cancer, its stage as well as patient's overall health.
Mechanism Of Action
Cytokast 50mg contains 50mg of cyclophosphamide as its active salt. Cyclophosphamide is a prodrug activated in the liver by cytochrome P450 enzymes to its activated and functional form. This causes cross-links that inhibit replication and lead to cancer cell death, primarily in proliferating cells.As a result, cancer cell growth stops.
Safety Advice
Alcohol
unsafe
It is generally recommended to avoid or limit alcohol consumption while patient is on Cytokast 50mg Injection course. Consult your doctor for personalized guidance.
Driving
consult your doctor
Cytokast 50mg Injection administration lead to side effects such as diziness, headache, nausea etc that can affect the patient's ability to drive. Therefore, it is not recommended to drive. Consult your doctor for more information.
Pregnancy
consult your doctor
Cytokast 50mg Injection administration is not allowed during pregnancy period as it can cause harm to growing baby in womb. Talk to your doctor about the same.
Breast Feeding
consult your doctor
Breastfeeding should also be discontinued while mother is on Cytokast 50mg Injection course. To know more, seek personal guidance from your doctor.
Kidney
caution
Share your medical history details related to kidney cancer or any other disease with your doctor before taking Cytokast 50mg Injection. As it may weaken the kidney.
Liver
caution
Notify your doctor about any liver disease or infection before starting Cytokast 50mg Injection course.As it can cause mild condition like jaundice to serious liver damage.
Faqs
Cytokast Injection is used to treat multiple cancers including lymphomas, leukemias, breast cancer, ovarian cancer, Neuroblastoma, multiple myeloma, and sarcomas.
Cytokast 50mg Injection inhibit cancer cell replication and lead to cancer cell death, primarily in proliferating cells. As a result, cancer cell growth stops.
No, it is not advised to self administer the Cytokast Injection until and unless you yourself are not a doctor or professional, experienced health care personnel.
No, Cytokast Injection is not recommended for administration during pregnancy. It causes harm to developing baby in the womb.
Yes, there are serious side effects of Cytokast 50mg Injection such as Secondary Cancer or Diseases, Peripheral Neuropathy, Febrile Nutropenia etc.
References
• Sharata, E. E., Bakry, T., Atta, H. G., Mohammed, H. A., Diab, N. S., Atef, R. A., ... & Hemeida, R. A. (2025). Molecular mechanisms underlying cyclophosphamide-induced ovarian injury and protective strategies. Naunyn-Schmiedeberg's archives of pharmacology, 1-35.
• Ge, Y., Domschke, C., Stoiber, N., Schott, S., Heil, J., Rom, J., ... & Schuetz, F. (2012). Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome. Cancer immunology, immunotherapy, 61(3), 353-362.
• Emadi, A., Jones, R. J., & Brodsky, R. A. (2009). Cyclophosphamide and cancer: golden anniversary. Nature reviews Clinical oncology, 6(11), 638-647.
• Voelcker, G. (2020). The mechanism of action of cyclophosphamide and its consequences for the development of a new generation of oxazaphosphorine cytostatics. Scientia pharmaceutica, 88(4), 42.
Related Products
MARKETER DETAILS
Aprazer Healthcare Pvt Ltd
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.